Westchester Capital Management (New York)’s Molecular Partners MOLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,000
Closed -$20K 430
2021
Q4
$20K Hold
1,000
﹤0.01% 384
2021
Q3
$20K Hold
1,000
﹤0.01% 356
2021
Q2
$20K Buy
+1,000
New +$19.8K ﹤0.01% 325

Other funds holding MOLN

Westchester Capital Management (New York)'s MOLN Position: Q1 2022 in Review

Westchester Capital Management (New York) sold out of Molecular Partners (MOLN) in Q1 2022, closing a stake of 1,000 shares — an estimated $20K sold.

Westchester Capital Management (New York) first reported a position in MOLN in Q2 2021 and held it in 3 quarters. The position peaked at $20K in Q4 2021. 8 funds tracked by Wall St. Rank hold MOLN as of Q1 2022.

  • Westchester Capital Management (New York) reported no remaining Molecular Partners position as of Q1 2022 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 1,000 Molecular Partners shares in Q1 2022, an estimated $20K.
  • Westchester Capital Management (New York) first reported a position in Molecular Partners in Q2 2021 and held it in 3 quarters.
  • Westchester Capital Management (New York)'s Molecular Partners position peaked at $20K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Molecular Partners as of Q1 2022.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2022, filed 16 May 2022.